4.6 Article

A strategy for early detection of response to chemotherapy drugs based on treatment-related changes in the metabolome

Related references

Note: Only part of the references are listed.
Meeting Abstract Oncology

A phase II trial of second-line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma (HCC).

Mairead Geraldine McNamara et al.

JOURNAL OF CLINICAL ONCOLOGY (2014)